<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>67(2)</volume><submitter>Ellekjaer KL</submitter><funding>Rigshospitalet</funding><funding>Grosserer Jakob Ehrenreich og Hustru Grete Ehrenreichs Fond</funding><funding>The Danish Society of Anesthesiology and Intensive Care Medicine (DASAIM)</funding><funding>DASAIM</funding><pubmed_abstract>&lt;h4>Background&lt;/h4>Intravenous (IV) fluid therapy is a ubiquitous intervention in daily clinical practice. However, nationwide detailed hospital- and departmental-level information on IV fluid use is limited. Hence, we aimed to describe the current issuing of isotonic crystalloid solutions across Danish public hospitals.&lt;h4>Methods&lt;/h4>We conducted a nationwide, retrospective observational study describing the issuing of isotonic crystalloid solutions for IV administration, including 0.9% saline, acetate- and lactate-buffered crystalloid solutions. We assessed fluid issuing at national-, regional-, hospital- and departmental-level from 1 January 2021 to 31 December 2021. We obtained sales figures from the Danish Regional Hospital Pharmacies. Regional characteristics were acquired from the </pubmed_abstract><journal>Acta anaesthesiologica Scandinavica</journal><pagination>177-184</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10108167</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Issuing of isotonic crystalloid solutions to Danish public hospitals in 2021-A retrospective nationwide observational study.</pubmed_title><pmcid>PMC10108167</pmcid><pubmed_authors>Ellekjaer KL</pubmed_authors><pubmed_authors>Perner A</pubmed_authors><pubmed_authors>Moller MH</pubmed_authors><pubmed_authors>Bruun Svan K</pubmed_authors></additional><is_claimable>false</is_claimable><name>Issuing of isotonic crystalloid solutions to Danish public hospitals in 2021-A retrospective nationwide observational study.</name><description>&lt;h4>Background&lt;/h4>Intravenous (IV) fluid therapy is a ubiquitous intervention in daily clinical practice. However, nationwide detailed hospital- and departmental-level information on IV fluid use is limited. Hence, we aimed to describe the current issuing of isotonic crystalloid solutions across Danish public hospitals.&lt;h4>Methods&lt;/h4>We conducted a nationwide, retrospective observational study describing the issuing of isotonic crystalloid solutions for IV administration, including 0.9% saline, acetate- and lactate-buffered crystalloid solutions. We assessed fluid issuing at national-, regional-, hospital- and departmental-level from 1 January 2021 to 31 December 2021. We obtained sales figures from the Danish Regional Hospital Pharmacies. Regional characteristics were acquired from the </description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Feb</publication><modification>2025-07-10T03:08:20.252Z</modification><creation>2025-04-06T11:20:35.491Z</creation></dates><accession>S-EPMC10108167</accession><cross_references><pubmed>36437485</pubmed><doi>10.1111/aas.14176</doi></cross_references></HashMap>